Investigators from Mass General Brigham and Beth Israel Deaconess Medical Center have developed STITCHR, a new gene editing tool that can insert therapeutic genes into specific locations without causing unwanted mutations. The system can be formulated completely as RNA, dramatically simplifying delivery logistics compared to traditional systems that use both RNA and DNA.  Source: Massachusetts General Brigham

Northwestern University researchers have developed the first wearable device for measuring gases emitted from and absorbed by the skin.

By analyzing these gases, the device offers an entirely new way to assess skin health, including monitoring wounds, detecting skin infections, tracking hydration levels, quantifying exposure to harmful environmental chemicals and more. Source: Northwestern Now

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by University College London researchers. Source: University College London News

Blood clots are associated with life-threatening conditions such as sepsis, sickle cell disease, heart attack and stroke. However, new research from Emory University may revolutionize how clinicians understand and treat these harmful blood clots, or thrombi, a byproduct of a condition called thromboinflammation. 

In a groundbreaking study published in Nature, researchers have discovered the potential to provide life-saving medications to patients with blood clots at the right time, with the right dose, in novel combinations based on a new model.  Source: Emory University News Center

While medical centers use ultrasound daily, so far this technology has not been capable of observing body tissues at the scale of cells. Physicists at several universities including CalTech have now developed a microscopy technique based on ultrasound to reveal capillaries and cells across living organs -- something that wasn't possible before. Source: Delft University of Technology

Drug-carrying DNA snippets called aptamers can deliver a one-two punch to leukemia by precisely targeting the elusive cancer stem cells that seed cancer relapses, researchers at the University of Illinois Urbana-Champaign report.

The aptamers — short single-strand snippets of DNA that can target molecules like larger antibodies do — not only deliver cancer-fighting drugs, but also are themselves toxic to the cancer stem cells, the researchers said.

Source: University of Illinois Urbana-Champaign News.

Brain cancer is the second most common cancer in children after leukemia, and it is also the deadliest, due to the fact that brain tumors are diverse, resistant to treatments and often hard to access surgically. A collaborative team of researchers at several institutions have developed a new way to profile brain cancers in children, paving the way for improved diagnostics and treatments. Source: UTSA Today

College athletes want to know when they can return to playing sports after a concussion. NIH-funded researchers have developed a new prognostic model.

Many cancer drugs fail to penetrate deep into tumors, but new research suggests magnetism could help pull them through.